IZEA:NASDAQIZEA Worldwide, Inc. Analysis
Data as of 2026-06-01 - not real-time
$3.74
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
IZEA trades at $3.74, just above the 20‑day SMA of $3.95 and the 50‑day SMA of $3.96, but still below the 200‑day SMA of $4.18, signaling a bearish longer‑term bias. The RSI sits at 41, indicating modest downside momentum, while the MACD line is negative and the histogram is shrinking, confirming a bearish signal. Current price hovers near the computed support level of $3.62 and faces resistance around $4.54, with volume trending downward and 30‑day volatility spiking above 40%, suggesting heightened short‑term risk. Fundamentally, the company posted a 17.5% revenue decline, negative operating and profit margins, and a forward PE of –9.1, reflecting earnings weakness. However, IZEA holds $46.5 M in cash, carries no debt, and trades at a price‑to‑book of 1.34, implying a cushion of net assets relative to market value. Recent news highlights a strategic exit from low‑margin SMB customers and a pivot toward enterprise‑focused influencer campaigns powered by AI tools, which could improve margin profiles over the next two years.
The combination of a cash‑rich balance sheet, a clear strategic shift, and a low beta of 0.44 tempers the downside, but the recent max drawdown of –41% and a bearish technical outlook keep the near‑term outlook cautious. Given the extreme greed sentiment in broader markets (Fear‑Greed Index 93.3) and the company’s under‑performance versus industry PE averages, the stock appears undervalued on a book basis but faces significant execution risk. Investors should weigh the potential upside from enterprise growth against the current earnings drag and elevated volatility.
The combination of a cash‑rich balance sheet, a clear strategic shift, and a low beta of 0.44 tempers the downside, but the recent max drawdown of –41% and a bearish technical outlook keep the near‑term outlook cautious. Given the extreme greed sentiment in broader markets (Fear‑Greed Index 93.3) and the company’s under‑performance versus industry PE averages, the stock appears undervalued on a book basis but faces significant execution risk. Investors should weigh the potential upside from enterprise growth against the current earnings drag and elevated volatility.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below all major moving averages
- Bearish MACD and decreasing volume
- Proximity to support with high volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strategic shift to enterprise and AI‑driven platforms
- Strong cash position and zero debt
- Continued revenue decline and negative margins
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential margin improvement from enterprise focus
- Undervalued book value relative to market price
- Low beta and ample cash providing runway for turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth-17.50%
Profit Margin-1.98%
P/E Ratio-9.1
ROE-1.23%
ROA-2.58%
P/B Ratio1.3
Op. Cash Flow$-3565743
Free Cash Flow$-5523936
Industry P/E17.1
Technical Analysis
TrendBearish
RSI41.1
Support$3.62
Resistance$4.54
MA 20$3.95
MA 50$3.96
MA 200$4.18
MACDBearish
VolumeDecreasing
Fear & Greed Index93.32
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.44
Volatility40.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.